CANERTINIB DIHYDROCHLORIDE CAS No. 289499-45-2 Pharmaceutical Intermediates
overview
Canertinib Dihydrochloride is a potent, irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, which plays a crucial role in the proliferation and survival of cancer cells.
By targeting the EGFR pathway, Canertinib Dihydrochloride effectively disrupts the signaling that promotes tumor growth, making it a valuable therapeutic option for patients with various types of cancer, particularly non-small cell lung cancer (NSCLC) and head and neck cancers.
Our Canertinib Dihydrochloride is produced under strict quality control measures, ensuring that it meets the highest standards for purity and efficacy.
Physical and Chemical Properties
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, while exhibiting limited solubility in water.
- Melting Point: Approximately 150-155°C.
- Stability: Stable under proper storage conditions.
The chemical structure of Canertinib Dihydrochloride features a unique combination of a quinazoline ring and a chlorobenzene moiety, which are essential for its biological activity.
This structure allows Canertinib Dihydrochloride to effectively bind to the EGFR tyrosine kinase domain, inhibiting its activity and preventing downstream signaling that leads to cancer cell proliferation.
1. Effective Cancer Treatment: Canertinib Dihydrochloride has demonstrated significant efficacy in inhibiting tumor growth in various preclinical and clinical studies, particularly in EGFR-mutant NSCLC.
2. Irreversible Inhibition: Unlike reversible inhibitors, Canertinib Dihydrochloride provides long-lasting inhibition of EGFR, potentially leading to improved therapeutic outcomes.
3. Broad Application: Canertinib Dihydrochloride is being investigated for use in combination therapies, enhancing its effectiveness in treating resistant cancer types.
4. Regulatory Compliance: Our Canertinib Dihydrochloride complies with international regulations, ensuring its suitability for use in global markets.
To ensure optimal results in your research and applications involving Canertinib Dihydrochloride, we offer a range of laboratory equipment and supplies, including:
- High-Performance Liquid Chromatography (HPLC) Systems: Essential for the analysis and quantification of Canertinib Dihydrochloride in various formulations.
- Mass Spectrometers: For precise identification and quantification of Canertinib Dihydrochloride and its metabolites.
- Reagents and Standards: High-quality reagents and calibration standards to ensure accurate and reliable results in your experiments.
- Storage Solutions: Specialized containers and conditions to maintain the stability and integrity of Canertinib Dihydrochloride.
Canertinib Dihydrochloride is a promising therapeutic agent for the treatment of various cancers, particularly those driven by EGFR signaling. Our Canertinib Dihydrochloride is sourced from reputable manufacturers and undergoes rigorous testing to ensure compliance with international standards.
As a leading foreign trade company, we are committed to providing high-quality products and exceptional customer service. We understand the importance of reliable supply chains and offer flexible ordering options to accommodate your specific needs.
Our dedicated team of experts is always available to provide technical support and guidance, ensuring that you can make the most of our products. With our high-quality Canertinib Dihydrochloride and comprehensive support, you can trust us to meet your needs effectively.
Whether you are in the pharmaceutical industry, academic research, or any other field requiring high-quality Canertinib Dihydrochloride, we are here to support your success.
Contact us today to learn more about our products and how we can assist you in achieving your research and development goals.